Genetic mutations in both the UPR pathway and NOD1/2 signaling have been linked to increased risk of inflammatory bowel disease (IBD), suggesting that these pathways are connected to both pathogen response and chronic inflammatory disease development (26, 27). This evidence concerns the gene NOD1 and inflammatory bowel disease.